UPN1826_Guth_13_S17_L002_R1_001.fastq.gz

syn25874637

Created By Elliot Stieglitz estieglitz

age: 0.0
sex: Male
Uuid: 63fc316f-4193-40c1-8e66-4678e74b7efb
assay: bisulfite sequencing
organ:
tissue: blood
ageUnit: months
runType: pairedEnd
species: Homo sapiens
studyId: syn51133946
cellType:
comments:
dataType: chromatinActivity
entityId: syn25874637
platform: Illumina NovaSeq 6000
readPair: 1
Component: EpigeneticsAssayTemplate
aliquotID:
diagnosis:
readDepth:
studyName: DHART SPORE Project 3 Phase 1 - A High Content Clinical Trial of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML)
tumorType: Juvenile Myelomonocytic Leukemia
fileFormat: fastq
initiative: Developmental and HyperActive Ras Tumor Specialized Programs of Research Excellence
isCellLine: No
readLength: 150
specimenID: UPN1826_Guth_13
assayTarget:
dataSubtype: raw
libraryPrep:
nf1Genotype: Unknown
nf2Genotype: Unknown
individualID: UPN1826_Guth_13
resourceType: experimentalData
fundingAgency: NIH-NCI
genePerturbed:
isPrimaryCell: Yes
timePointUnit:
modelSystemName:
parentSpecimenID: UPN1826_Guth_13
nucleicAcidSource: bulk cell
dissociationMethod:
genePerturbationType: Not Applicable
progressReportNumber:
experimentalCondition:
experimentalTimepoint:
libraryPreparationMethod:
specimenPreparationMethod:
genePerturbationTechnology:

UPN1826_Guth_13_S17_L002_R1_001.fastq.gz page is loading…